12.3 C
New York
Thursday, April 21, 2022

Life-extending breast cancer drug Ibrance to be fully funded from April

A life-prolonging drug is being fully funded for New Zealanders with advanced (metastatic) breast cancer, saving patients thousands of dollars and ultimately giving them more time. 
On Thursday, Pharmac announced it was funding Ibrance (palbociclib) from Ap… [+3370 chars]Source

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

21,861FansLike
3,264FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles